Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 58:135-138, January 2007
doi: 10.1176/appi.ps.58.1.135
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fischer, M. A.
* Articles by Wang, P. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Fischer, M. A.
* Articles by Wang, P. S.
Related Collections
* Child/Adolescent Psychiatry
* Health Insurance
* Access to Services
* Other Health Services Issues
* Other Childhood Disorders
* Depression
* Antidepressants
*Related Article

Brief Report

Restrictions on Antidepressant Medications for Children: A Review of Medicaid Policy

Michael A. Fischer, M.D., M.S., Amber D. Servi, A.B., Jennifer M. Polinski, M.P.H. and Philip S. Wang, M.D., Dr.Ph.

OBJECTIVE: This study evaluated Medicaid's prior-authorization policies restricting the prescribing of antidepressant medications for children. METHODS: Medicaid program prior-authorization policies for antidepressant medications were obtained for all available states. All criteria needed for authorization were recorded, with a focus on policies that applied specifically to children. RESULTS: Data from 49 states and the District of Columbia revealed that 30 states (60%) required prior authorization for antidepressants, of which eight (27%) made specific provisions for children. These provisions varied across states. In most states fluoxetine could be prescribed for children with minimal restrictions, and two states had prior-authorization policies that strongly encouraged pediatric patients to use fluoxetine. State policies regarding other selective serotonin reuptake inhibitors varied widely. CONCLUSIONS: Although relatively few states included provisions for children in prior-authorization requirements for antidepressants, in states that did, the policies implemented varied widely. These findings raise important questions about the rational development of prescription drug reimbursement policy.


Related Article:

January 2007: This Month's Highlights
Psychiatr Serv 2007 58: 7. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
J. M. Polinski, P. S. Wang, and M. A. Fischer
Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Health Aff., May 1, 2007; 26(3): 750 - 760.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org